Friday, November 9, 2018

The promise of personalized medicine in cancer remains elusive, because no single technology can comprehensively detect all the rearrangements in the cancer genome. Bionano genome mapping detects all structural variant types genome-wide. Examples will be presented of how Bionano’s platform helps provide a molecular diagnosis for patients with undiagnosed genetic disorders, and how it elucidates genomic rearrangements in cancer that are missed by NGS and cytogenetic methods.

Lunch will be provided for those who register.


November 9, 2018
12:00pm-1:00am PST
107 A/B

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.